A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
Clinical trial NCT02693652 · COMPLETED
Trial details
- NCT number
- NCT02693652
- Sponsor
- Aribio Lab Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2017-08-22
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.